Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25056481 |
US |
2 | |
Blood glucose increased, Feeling abnormal, Glycosylated haemoglobin decreased, |
||||
LINAGLIPTIN, |
||||
| 402 | 25056807 |
US |
2 | |
Incorrect dose administered, Glycosylated haemoglobin increased, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
| 403 | 25056996 |
CN |
39 | 1 |
Psoas abscess, Blood glucose increased, Device information output issue, Product storage error, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 404 | 25057008 |
US |
63 | 2 |
Bipolar disorder, Abdominal pain, Diarrhoea, Constipation, Blood glucose increased, Off label use, |
||||
SEMAGLUTIDE, PREDNISONE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, ARIPIPRAZOLE, ARIPIPRAZOLE, |
||||
| 405 | 25057018 |
US |
2 | |
Fall, Full blood count abnormal, Blood glucose increased, Inappropriate schedule of product administration, |
||||
SEMAGLUTIDE, |
||||
| 406 | 25057408 |
US |
65 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 407 | 25057413 |
US |
13 | 2 |
Infection, Product storage error, Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, |
||||
| 408 | 25058050 |
ZA |
56 | |
Transient ischaemic attack, Blood glucose increased, |
||||
DAPAGLIFLOZIN, ALLOPURINOL, AMLODIPINE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, |
||||
| 409 | 25058970 |
US |
68 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, SEMAGLUTIDE, |
||||
| 410 | 25059527 |
CA |
49 | 2 |
Back pain, Blood glucose increased, Blood pressure increased, Bone pain, Feeling abnormal, Gait disturbance, Injection site pruritus, Mastocytosis, Osteoporosis, Perfume sensitivity, Pruritus, Scratch, Skin reaction, Hypersensitivity, Asthenia, Urticaria, Drug ineffective, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CROMOLYN SODIUM, FENTANYL, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE, KETOTIFEN FUMARATE, KETOTIFEN FUMARATE, KETOTIFEN FUMARATE, KETOTIFEN FUMARATE, OXYCODONE, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, MONTELUKAST SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
| 411 | 25059679 |
US |
65 | 2 |
Blood glucose increased, Extra dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 412 | 25059684 |
US |
59 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 413 | 25060364 |
US |
77 | 1 |
Ankle fracture, Localised infection, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 414 | 25060540 |
US |
64 | 1 |
Feeding disorder, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 415 | 25060602 |
US |
71 | 2 |
Muscle spasms, Neuralgia, Myalgia, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 416 | 25060606 |
US |
48 | 1 |
Diabetic ketoacidosis, Weight decreased, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 417 | 25060756 |
US |
60 | 2 |
Malaise, Blood glucose increased, Off label use, |
||||
INSULIN HUMAN, INSULIN HUMAN, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 418 | 25060762 |
US |
67 | 2 |
Hepatic pain, Pancreatitis, Blood glucose increased, Muscular weakness, Pain, Pain in extremity, Nervous system disorder, Hepatic function abnormal, Asthenia, Blood glucose decreased, |
||||
DULAGLUTIDE, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, EVOLOCUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 419 | 25060955 |
US |
70 | 1 |
Blood glucose increased, Device operational issue, |
||||
INSULIN GLARGINE, |
||||
| 420 | 25055626 |
US |
||
Glycosylated haemoglobin increased, Blood glucose increased, |
||||
CABOTEGRAVIR, |
||||
| 421 | 25055784 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 422 | 25055998 |
US |
73 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 423 | 25056006 |
US |
28 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 424 | 25056053 |
US |
67 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 425 | 25056213 |
JP |
70 | 1 |
Atonic seizures, Loss of consciousness, Loss of consciousness, Atonic seizures, Epilepsy, Hypoglycaemia, Blood glucose increased, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, PIOGLITAZONE, ISOSORBIDE MONONITRATE, VALSARTAN, EZETIMIBE, PITAVASTATIN CALCIUM, PITAVASTATIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, |
||||
| 426 | 25056229 |
CA |
42 | 2 |
Fall, Blood pressure increased, Limb injury, Pain in extremity, Therapeutic response shortened, Joint swelling, Subcutaneous abscess, Arthralgia, Blood glucose increased, Pain, Hidradenitis, Hypoaesthesia, Asthenia, Paraesthesia, Off label use, Inappropriate schedule of product administration, |
||||
IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FOLIC ACID, FENOFIBRATE, METHOTREXATE, METHOTREXATE SODIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHYLPREDNISOLONE, SEMAGLUTIDE, PREGABALIN, ALBUTEROL SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BUPROPION HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, MEDROXYPROGESTERONE ACETATE, |
||||
| 427 | 25056232 |
US |
||
Diabetes mellitus, Product dose omission issue, Blood glucose increased, Fatigue, Asthenia, |
||||
DAPAGLIFLOZIN, |
||||
| 428 | 25054795 |
US |
69 | 1 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, HYDRALAZINE HYDROCHLORIDE, REPAGLINIDE, |
||||
| 429 | 25055086 |
US |
67 | 1 |
Blood glucose increased, Dizziness, Product storage error, |
||||
ADALIMUMAB, |
||||
| 430 | 25048240 |
US |
58 | 2 |
Sinusitis, Cold sweat, Blood glucose increased, Discomfort, Chest discomfort, Dizziness, Flatulence, Glycosylated haemoglobin increased, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 431 | 25048408 |
IN |
76 | 1 |
Prostatic operation, Blood glucose fluctuation, Blood glucose increased, Suspected product quality issue, |
||||
| 432 | 25048579 |
CO |
61 | 2 |
Blood glucose increased, Syncope, Hypertension, Myocardial infarction, Loss of consciousness, Constipation, Fatigue, |
||||
INSULIN DEGLUDEC, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 433 | 25048910 |
US |
2 | |
Vision blurred, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 434 | 25048922 |
US |
70 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 435 | 25048966 |
US |
60 | 2 |
Diabetic ketoacidosis, Vomiting, Blood glucose increased, |
||||
PASIREOTIDE, PASIREOTIDE, PASIREOTIDE, GLIMEPIRIDE, INSULIN DETEMIR, LORAZEPAM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, INSULIN ASPART, PRAVASTATIN SODIUM, SERTRALINE HYDROCHLORIDE, LISINOPRIL, ESCITALOPRAM, ESCITALOPRAM, |
||||
| 436 | 25049189 |
US |
66 | 1 |
Blood glucose increased, Nausea, Abdominal distension, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 437 | 25049242 |
US |
68 | 1 |
Blood glucose increased, Confusional state, |
||||
RIFAXIMIN, |
||||
| 438 | 25049264 |
US |
79 | 1 |
Drug ineffective, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 439 | 25049337 |
US |
58 | 2 |
Hypoaesthesia oral, Throat irritation, Dizziness, Panic attack, Memory impairment, Visual impairment, Blood glucose increased, Nasal oedema, Hypoaesthesia, Fatigue, Swollen tongue, Vomiting, Dehydration, Pharyngeal swelling, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, SEMAGLUTIDE, |
||||
| 440 | 25050531 |
US |
||
Blood glucose increased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 441 | 25051509 |
US |
42 | 2 |
Thirst, Abdominal pain upper, Blood glucose increased, Blood pressure increased, Pollakiuria, Dizziness, |
||||
BUDESONIDE, |
||||
| 442 | 25051884 |
US |
54 | 1 |
Dyspnoea, Histology abnormal, Blood glucose increased, Blood pressure increased, Ill-defined disorder, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 443 | 25051942 |
US |
35 | |
Neutrophil count increased, Blood glucose increased, Blood creatinine increased, Blood calcium increased, Lymphocyte count decreased, |
||||
RAVULIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, AZATHIOPRINE, CARVEDILOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM OXIDE, POTASSIUM PHOSPHATE, TACROLIMUS, |
||||
| 444 | 25052257 |
US |
63 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
DULAGLUTIDE, |
||||
| 445 | 25052539 |
US |
27 | 2 |
Diabetic ketoacidosis, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, |
||||
| 446 | 25052718 |
US |
76 | 2 |
Respiratory distress, Subclavian artery occlusion, Carotid endarterectomy, Oedema peripheral, High density lipoprotein decreased, Blood triglycerides increased, Blood glucose increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, ERENUMAB-AOOE, ALIROCUMAB, VITAMIN C, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, EFINACONAZOLE, EZETIMIBE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, IPRATROPIUM BROMIDE, MAGNESIUM CHLORIDE, MESALAMINE, METOPROLOL SUCCINATE, OMEGA-3-ACID ETHYL ESTERS, KENALOG, VITAMIN E, CREAM, ZINC GLUCONATE, |
||||
| 447 | 25052767 |
US |
56 | 2 |
Blood glucose increased, Device issue, Product dispensing error, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 448 | 25053164 |
US |
1 | |
Blood glucose decreased, Blood glucose increased, Intentional product use issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 449 | 25053195 |
US |
83 | 1 |
Blood glucose increased, Drug ineffective, Device issue, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 450 | 25053249 |
US |
78 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 451 | 25053362 |
US |
67 | 1 |
Blood glucose increased, Illness, |
||||
INSULIN GLARGINE, |
||||
| 452 | 25053442 |
US |
2 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 453 | 25053457 |
US |
48 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 454 | 25053586 |
US |
74 | 1 |
Blood glucose increased, Device issue, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 455 | 25053642 |
US |
49 | 1 |
Wound, Blood glucose increased, Expired product administered, |
||||
INSULIN GLARGINE, |
||||
| 456 | 25053751 |
US |
1 | |
Blood glucose increased, Cough, Feeling abnormal, Hypoglycaemia, Injection site discomfort, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, MONTELUKAST, CETIRIZINE HYDROCHLORIDE, |
||||
| 457 | 25053819 |
US |
||
Poor quality product administered, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 458 | 25054036 |
US |
2 | |
Injury associated with device, Blood glucose increased, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 459 | 25054100 |
US |
87 | 2 |
Blood glucose increased, Drug dose omission by device, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 460 | 25054197 |
US |
54 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 461 | 25054228 |
US |
10 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 462 | 25054295 |
US |
30 | 1 |
Blood glucose increased, Intentional product misuse, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN DETEMIR, |
||||
| 463 | 25054365 |
US |
59 | 1 |
Panic reaction, Anxiety, Insomnia, Blood glucose increased, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 464 | 25054396 |
US |
1 | |
Blood glucose increased, Product quality issue, |
||||
INSULIN GLARGINE, |
||||
| 465 | 25054530 |
US |
78 | 1 |
Blood glucose increased, |
||||
DUPILUMAB, |
||||
| 466 | 25043426 |
US |
71 | 2 |
Blood glucose increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 467 | 25043751 |
US |
56 | 2 |
Blood glucose increased, Drug ineffective, Fungal infection, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 468 | 25044019 |
US |
60 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 469 | 25044112 |
JP |
1 | |
Depressed level of consciousness, Peripheral swelling, Pain in extremity, Gastric polyps, Abdominal pain upper, Arthralgia, Myalgia, Palpitations, Glycosylated haemoglobin increased, Blood glucose increased, Drug interaction, Off label use, |
||||
VONOPRAZAN FUMARATE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, CARBAMAZEPINE, CARVEDILOL, AMLODIPINE BESYLATE, CANDESARTAN CILEXETIL, ASENAPINE MALEATE, |
||||
| 470 | 25044205 |
GT |
43 | 2 |
Multiple sclerosis, Blood glucose increased, Pain, Headache, |
||||
NATALIZUMAB, ERGOCALCIFEROL, |
||||
| 471 | 25044700 |
US |
85 | 1 |
Spinal stenosis, Blood glucose increased, Injection site bruising, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 472 | 25044978 |
US |
||
Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, ENZALUTAMIDE, |
||||
| 473 | 25045087 |
US |
30 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 474 | 25045477 |
US |
||
Feeling abnormal, Fatigue, Hot flush, Asthenia, Blood glucose increased, Headache, |
||||
RELUGOLIX, RELUGOLIX, AMLODIPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, TADALAFIL, ERGOCALCIFEROL, |
||||
| 475 | 25045504 |
US |
||
Hot flush, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 476 | 25046233 |
US |
63 | 1 |
Blood glucose increased, Product storage error, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 477 | 25046582 |
RO |
||
Sepsis, Cardiac arrest, Cardio-respiratory arrest, Necrotising fasciitis, White blood cell count increased, Neutrophil count increased, Haemoglobin decreased, Blood creatinine increased, Red blood cell sedimentation rate increased, Urine protein/creatinine ratio increased, Blood glucose increased, |
||||
DAPAGLIFLOZIN, |
||||
| 478 | 25046614 |
CA |
1 | |
Cerebrovascular accident, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 479 | 25046626 |
JP |
||
Blood glucose increased, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 480 | 25046629 |
DE |
75 | 1 |
Myocardial infarction, Blood glucose increased, Product administered at inappropriate site, Incorrect dose administered, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 481 | 25047378 |
US |
72 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 482 | 25039303 |
US |
70 | 1 |
Accidental overdose, Injection site pain, Injection site haemorrhage, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 483 | 25039313 |
IN |
1 | |
Retinal exudates, Blood glucose increased, |
||||
RANIBIZUMAB, |
||||
| 484 | 25039729 |
US |
53 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 485 | 25040305 |
US |
70 | 2 |
Cataract, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, |
||||
| 486 | 25040423 |
US |
||
Blood glucose increased, Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, DAROLUTAMIDE, |
||||
| 487 | 25040495 |
US |
||
Blood glucose increased, Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, ENZALUTAMIDE, |
||||
| 488 | 25040616 |
US |
1 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 489 | 25040839 |
VN |
||
Chronic graft versus host disease, Seizure, Cytomegalovirus infection reactivation, Acute graft versus host disease, Hypertension, Blood glucose increased, Blood creatinine increased, Hepatic enzyme increased, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 490 | 25041552 |
US |
2 | |
Blood glucose increased, Accidental underdose, |
||||
INSULIN LISPRO, |
||||
| 491 | 25041557 |
US |
63 | 2 |
Gastric haemorrhage, Gastric cancer, Urinary bladder rupture, Urinary bladder haemorrhage, Hepatic cirrhosis, Liver disorder, Blood glucose increased, Blood glucose abnormal, Weight decreased, Headache, Rash, |
||||
INSULIN LISPRO, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, SEMAGLUTIDE, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 492 | 25042661 |
CN |
33 | 2 |
Haematochezia, Blood glucose increased, Insulin-like growth factor increased, Tri-iodothyronine decreased, Thyroxine decreased, Haemorrhoids, Alopecia, Cardiac disorder, Chest discomfort, Liver disorder, Neck pain, Intervertebral disc protrusion, |
||||
LANREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE, LEVOTHYROXINE SODIUM, |
||||
| 493 | 25043188 |
DE |
1 | |
Blood glucose increased, Flushing, |
||||
DIROXIMEL FUMARATE, |
||||
| 494 | 25043249 |
US |
68 | 1 |
Hypoacusis, Inappropriate schedule of product administration, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 495 | 25034065 |
US |
2 | |
Influenza, Asthma, Pneumonia, Blood glucose increased, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 496 | 25034457 |
US |
71 | 1 |
Blindness, Blood glucose increased, Blood glucose fluctuation, Blood glucose increased, Feeling abnormal, Feeling abnormal, |
||||
HUMAN INSULIN, |
||||
| 497 | 25034460 |
CO |
60 | 1 |
Fall, Loss of consciousness, Hiccups, Throat tightness, Dizziness, Blood glucose increased, Inappropriate schedule of product administration, |
||||
ORAL SEMAGLUTIDE, |
||||
| 498 | 25034649 |
US |
41 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 499 | 25034725 |
US |
61 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 500 | 25034876 |
US |
59 | 2 |
Product dose omission issue, Blood glucose increased, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28